Hypercoagulability and cardiovascular disease in diabetic nephropathy

Area of Science:

• Nephrology
• Cardiology
• Hematology

Background:

• Diabetic nephropathy is a primary cause of end-stage renal disease and a significant cardiovascular disease risk factor.
• Elevated Von Willebrand factor (VWF) and decreased ADAMTS13 levels are observed in diabetic nephropathy, suggesting hypercoagulability.
• The precise roles of VWF and ADAMTS13 in cardiovascular event development and the impact of renal injury on ADAMTS13 are not fully understood.

Purpose of the Study:

• To review the association between diabetic nephropathy, atherosclerotic cardiovascular disease, and hypercoagulability markers (VWF and ADAMTS13).
• To explore the mechanisms by which renal dysfunction influences ADAMTS13 metabolism and contributes to hypercoagulability.

Main Methods:

• Literature review focusing on diabetic nephropathy, cardiovascular disease, VWF, and ADAMTS13.
• Discussion of existing research on hypercoagulability markers in diabetic patients with impaired renal function.

Main Results:

• Increased plasma VWF and reduced plasma ADAMTS13 are associated with diabetic nephropathy and cardiovascular risk.
• Renal injury may lead to decreased ADAMTS13 levels, promoting a hypercoagulable state.

Conclusions:

• Hypercoagulability markers, VWF and ADAMTS13, may actively contribute to cardiovascular disease risk in diabetic nephropathy.
• Understanding the interplay between renal dysfunction, ADAMTS13 metabolism, and hypercoagulability is crucial for managing cardiovascular risk in diabetic patients.